Morgan Stanley’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8M | Buy |
5,329,679
+3,032,005
| +132% | +$27.2M | ﹤0.01% | 1976 |
|
|
2025
Q1 | $17.2M | Buy |
2,297,674
+631,942
| +38% | +$4.74M | ﹤0.01% | 2847 |
|
|
2024
Q4 | $12.5M | Sell |
1,665,732
-73,348
| -4% | -$552K | ﹤0.01% | 3212 |
|
|
2024
Q3 | $13.2M | Buy |
1,739,080
+161,131
| +10% | +$1.22M | ﹤0.01% | 3208 |
|
|
2024
Q2 | $9.75M | Sell |
1,577,949
-430,096
| -21% | -$2.66M | ﹤0.01% | 3346 |
|
|
2024
Q1 | $10.2M | Sell |
2,008,045
-4,265,331
| -68% | -$21.7M | ﹤0.01% | 3334 |
|
|
2023
Q4 | $37.6M | Buy |
6,273,376
+4,447,552
| +244% | +$26.6M | ﹤0.01% | 2749 |
|
|
2023
Q3 | $12.9M | Buy |
1,825,824
+956,027
| +110% | +$6.77M | ﹤0.01% | 2881 |
|
|
2023
Q2 | $6.12M | Sell |
869,797
-740,873
| -46% | -$5.22M | ﹤0.01% | 3610 |
|
|
2023
Q1 | $13.4M | Buy |
1,610,670
+454,939
| +39% | +$3.79M | ﹤0.01% | 2864 |
|
|
2022
Q4 | $13.3M | Buy |
1,155,731
+246,462
| +27% | +$2.83M | ﹤0.01% | 2778 |
|
|
2022
Q3 | $11.5M | Sell |
909,269
-3,466,300
| -79% | -$43.7M | ﹤0.01% | 2802 |
|
|
2022
Q2 | $46.3M | Buy |
4,375,569
+3,665,522
| +516% | +$38.8M | 0.01% | 1427 |
|
|
2022
Q1 | $11.5M | Buy |
710,047
+333,678
| +89% | +$5.43M | ﹤0.01% | 2749 |
|
|
2021
Q4 | $5.21M | Sell |
376,369
-49,008
| -12% | -$679K | ﹤0.01% | 3677 |
|
|
2021
Q3 | $6.11M | Sell |
425,377
-486,828
| -53% | -$7M | ﹤0.01% | 3463 |
|
|
2021
Q2 | $14.4M | Buy |
912,205
+654,998
| +255% | +$10.4M | ﹤0.01% | 2549 |
|
|
2021
Q1 | $2.62M | Sell |
257,207
-17,940
| -7% | -$182K | ﹤0.01% | 4048 |
|
|
2020
Q4 | $2.05M | Buy |
275,147
+81,750
| +42% | +$609K | ﹤0.01% | 4137 |
|
|
2020
Q3 | $664K | Sell |
193,397
-18,996
| -9% | -$65.2K | ﹤0.01% | 4481 |
|
|
2020
Q2 | $1.01M | Sell |
212,393
-479,755
| -69% | -$2.29M | ﹤0.01% | 4157 |
|
|
2020
Q1 | $1.38M | Buy |
692,148
+183,081
| +36% | +$366K | ﹤0.01% | 3685 |
|
|
2019
Q4 | $1.76M | Sell |
509,067
-739,249
| -59% | -$2.55M | ﹤0.01% | 4134 |
|
|
2019
Q3 | $3.58M | Sell |
1,248,316
-164,337
| -12% | -$471K | ﹤0.01% | 3247 |
|
|
2019
Q2 | $5.35M | Buy |
1,412,653
+1,045,869
| +285% | +$3.96M | ﹤0.01% | 2856 |
|
|
2019
Q1 | $2.99M | Buy |
366,784
+183,081
| +100% | +$1.49M | ﹤0.01% | 3223 |
|
|
2018
Q4 | $1.48M | Sell |
183,703
-9,016
| -5% | -$72.8K | ﹤0.01% | 4005 |
|
|
2018
Q3 | $1.47M | Sell |
192,719
-48,610
| -20% | -$371K | ﹤0.01% | 4236 |
|
|
2018
Q2 | $1.38M | Sell |
241,329
-200,102
| -45% | -$1.15M | ﹤0.01% | 4393 |
|
|
2018
Q1 | $2.11M | Buy |
441,431
+52,726
| +14% | +$252K | ﹤0.01% | 3967 |
|
|
2017
Q4 | $1.91M | Buy |
388,705
+26,565
| +7% | +$130K | ﹤0.01% | 4071 |
|
|
2017
Q3 | $1.9M | Buy |
362,140
+44,241
| +14% | +$232K | ﹤0.01% | 3937 |
|
|
2017
Q2 | $1.77M | Sell |
317,899
-156,286
| -33% | -$869K | ﹤0.01% | 3910 |
|
|
2017
Q1 | $3.98M | Buy |
474,185
+146,220
| +45% | +$1.23M | ﹤0.01% | 3106 |
|
|
2016
Q4 | $2.08M | Buy |
327,965
+302,642
| +1,195% | +$1.92M | ﹤0.01% | 3893 |
|
|
2016
Q3 | $112K | Buy |
25,323
+8,529
| +51% | +$37.7K | ﹤0.01% | 5259 |
|
|
2016
Q2 | $48K | Sell |
16,794
-163,431
| -91% | -$467K | ﹤0.01% | 5547 |
|
|
2016
Q1 | $510K | Buy |
180,225
+76,421
| +74% | +$216K | ﹤0.01% | 4431 |
|
|
2015
Q4 | $1.07M | Buy |
103,804
+12,646
| +14% | +$130K | ﹤0.01% | 3999 |
|
|
2015
Q3 | $1.04M | Sell |
91,158
-7,934
| -8% | -$90.4K | ﹤0.01% | 4074 |
|
|
2015
Q2 | $1.48M | Buy |
99,092
+327
| +0.3% | +$4.88K | ﹤0.01% | 3895 |
|
|
2015
Q1 | $892K | Buy |
98,765
+37,571
| +61% | +$339K | ﹤0.01% | 4217 |
|
|
2014
Q4 | $745K | Sell |
61,194
-227,022
| -79% | -$2.76M | ﹤0.01% | 4368 |
|
|
2014
Q3 | $2.82M | Sell |
288,216
-202,818
| -41% | -$1.98M | ﹤0.01% | 3161 |
|
|
2014
Q2 | $6.26M | Sell |
491,034
-34,272
| -7% | -$437K | ﹤0.01% | 2465 |
|
|
2014
Q1 | $5.56M | Sell |
525,306
-7,706
| -1% | -$81.5K | ﹤0.01% | 2493 |
|
|
2013
Q4 | $4.05M | Buy |
533,012
+458,179
| +612% | +$3.48M | ﹤0.01% | 2768 |
|
|
2013
Q3 | $544K | Sell |
74,833
-104,494
| -58% | -$760K | ﹤0.01% | 4273 |
|
|
2013
Q2 | $278K | Buy |
+179,327
| New | +$278K | ﹤0.01% | 4646 |
|